These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36658674)

  • 1. Risk factors for taxane-induced peripheral neuropathy in patients with breast cancer.
    Liang C; Zhang Y; Chen QY; Chen WF; Chen MZ
    Asia Pac J Clin Oncol; 2024 Apr; 20(2):220-227. PubMed ID: 36658674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women With Early-Stage Breast Cancer.
    Schneider BP; Zhao F; Ballinger TJ; Garcia SF; Shen F; Virani S; Cella D; Bales C; Jiang G; Hayes L; Miller N; Srinivasiah J; Stringer-Reasor EM; Chitalia A; Davis AA; Makower DF; Incorvati J; Simon MA; Mitchell EP; DeMichele A; Miller KD; Sparano JA; Wagner LI; Wolff AC
    J Clin Oncol; 2024 Aug; 42(24):2899-2907. PubMed ID: 38828938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent taxane-induced neuropathy in elderly patients treated for localized breast cancer.
    Pabst L; Velten M; Fischbach C; Kalish M; Pflumio C; Pivot X; Petit T
    Breast J; 2020 Dec; 26(12):2376-2382. PubMed ID: 33307596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study.
    Zhai J; Sun X; Zhao F; Pan B; Li H; Lv Z; Cao M; Zhao J; Mo H; Ma F; Xu B
    Breast; 2023 Feb; 67():36-45. PubMed ID: 36586272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of taxane-induced peripheral neuropathy receiving treatment and prescription patterns in patients with breast cancer.
    Song SJ; Min J; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Support Care Cancer; 2017 Jul; 25(7):2241-2248. PubMed ID: 28204996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
    Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
    J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol.
    Sharma A; Johnson KB; Bie B; Rhoades EE; Sen A; Kida Y; Hockings J; Gatta A; Davenport J; Arcangelini C; Ritzu J; DeVecchio J; Hughen R; Wei M; Thomas Budd G; Lynn Henry N; Eng C; Foss J; Rotroff DM
    Technol Cancer Res Treat; 2022; 21():15330338221127169. PubMed ID: 36172750
    [No Abstract]   [Full Text] [Related]  

  • 8. Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer?
    Nicolae R; Uccellini A; Siderov J; Mellerick A; Wong V; Yeo B
    Asia Pac J Clin Oncol; 2023 Apr; 19(2):e118-e127. PubMed ID: 35692105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
    Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
    Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans.
    Schneider BP; Lai D; Shen F; Jiang G; Radovich M; Li L; Gardner L; Miller KD; O'Neill A; Sparano JA; Xue G; Foroud T; Sledge GW
    Oncotarget; 2016 Dec; 7(50):82244-82253. PubMed ID: 27732968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the traditional Chinese medicine, Buyang Huanwu Decoction, at preventing taxane-induced peripheral neuropathy in breast cancer patients: A prospective, randomized, controlled study.
    Luo F; Wan D; Liu J; Chen D; Yuan M; Zhang C; Liu Q
    Medicine (Baltimore); 2024 Mar; 103(9):e37338. PubMed ID: 38428887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci.
    Sucheston-Campbell LE; Clay-Gilmour AI; Barlow WE; Budd GT; Stram DO; Haiman CA; Sheng X; Yan L; Zirpoli G; Yao S; Jiang C; Owzar K; Hershman D; Albain KS; Hayes DF; Moore HC; Hobday TJ; Stewart JA; Rizvi A; Isaacs C; Salim M; Gralow JR; Hortobagyi GN; Livingston RB; Kroetz DL; Ambrosone CB
    Pharmacogenet Genomics; 2018 Feb; 28(2):49-55. PubMed ID: 29278617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199.
    Schneider BP; Li L; Radovich M; Shen F; Miller KD; Flockhart DA; Jiang G; Vance G; Gardner L; Vatta M; Bai S; Lai D; Koller D; Zhao F; O'Neill A; Smith ML; Railey E; White C; Partridge A; Sparano J; Davidson NE; Foroud T; Sledge GW
    Clin Cancer Res; 2015 Nov; 21(22):5082-5091. PubMed ID: 26138065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional study.
    Engvall K; Gréen H; Fredrikson M; Lagerlund M; Lewin F; Åvall-Lundqvist E
    Breast Cancer Res Treat; 2022 Oct; 195(3):379-391. PubMed ID: 35941422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxane-induced peripheral neuropathy and quality of life in breast cancer patients.
    Salehifar E; Janbabaei G; Alipour A; Tabrizi N; Avan R
    J Oncol Pharm Pract; 2020 Sep; 26(6):1421-1428. PubMed ID: 31937190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS).
    Williams LA; Garcia-Gonzalez A; Mendoza TR; Haq S; Cleeland CS
    Support Care Cancer; 2019 Mar; 27(3):1021-1028. PubMed ID: 30094731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Ganglioside-Monosialic Acid in Taxane-Induced Peripheral Neurotoxicity in Patients with Breast Cancer: A Randomized Trial.
    Su Y; Huang J; Wang S; Unger JM; Arias-Fuenzalida J; Shi Y; Li J; Gao Y; Shi W; Wang X; Peng R; Xu F; An X; Xue C; Xia W; Hong R; Zhong Y; Lin Y; Huang H; Zhang A; Zhang L; Cai L; Zhang J; Yuan Z
    J Natl Cancer Inst; 2020 Jan; 112(1):55-62. PubMed ID: 31093677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, description, predictors, and consequences of persistent taxane-induced peripheral neuropathy.
    Hertz DL
    Curr Opin Support Palliat Care; 2024 Mar; 18(1):30-38. PubMed ID: 38126251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and Tolerability of Nab-paclitaxel in Younger versus Elderly Patients With Metastatic HR-positive/HER2-negative Breast Cancer: Results From the Noninterventional, Prospective Study NABUCCO.
    Potthoff K; Stötzer O; Söling U; Hansen R; Harde J; Dille S; Nusch A; Marschner N
    Clin Breast Cancer; 2020 Jun; 20(3):e315-e326. PubMed ID: 32273207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    Greenlee H; Hershman DL; Shi Z; Kwan ML; Ergas IJ; Roh JM; Kushi LH
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27794123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.